Lord, Abbett & Co. LLC Intra Cellular Therapies, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $30.7 Billion
  • Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 628,839 shares of ITCI stock, worth $53.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
628,839
Previous 633,458 0.73%
Holding current value
$53.9 Million
Previous $43.4 Million 6.05%
% of portfolio
0.15%
Previous 0.14%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$67.99 - $80.84 $314,045 - $373,399
-4,619 Reduced 0.73%
628,839 $46 Million
Q2 2024

Oct 07, 2024
BUY
$64.76 - $79.84 $10.4 Million - $12.8 Million
160,771 Added 34.01%
633,458 $43.4 Million
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $10.4 Million - $12.8 Million
160,771 Added 34.01%
633,458 $43.4 Million
Q1 2024

Oct 07, 2024
SELL
$64.37 - $75.65 $19.3 Million - $22.7 Million
-300,280 Reduced 38.85%
472,687 $32.7 Million
Q1 2024

May 09, 2024
SELL
$64.37 - $75.65 $19.3 Million - $22.7 Million
-300,280 Reduced 38.85%
472,687 $32.7 Million
Q4 2023

Oct 07, 2024
BUY
$46.37 - $73.65 $5.61 Million - $8.91 Million
120,937 Added 18.55%
772,967 $55.4 Million
Q4 2023

Feb 12, 2024
BUY
$46.37 - $73.65 $5.61 Million - $8.91 Million
120,937 Added 18.55%
772,967 $55.4 Million
Q3 2023

Oct 07, 2024
SELL
$52.09 - $64.1 $33.4 Million - $41.1 Million
-640,738 Reduced 49.56%
652,030 $34 Million
Q3 2023

Nov 13, 2023
SELL
$52.09 - $64.1 $33.4 Million - $41.1 Million
-640,738 Reduced 49.56%
652,030 $34 Million
Q2 2023

Oct 07, 2024
BUY
$54.67 - $66.44 $32.2 Million - $39.1 Million
588,837 Added 83.65%
1,292,768 $81.9 Million
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $32.2 Million - $39.1 Million
588,837 Added 83.65%
1,292,768 $81.9 Million
Q1 2023

Oct 07, 2024
SELL
$43.8 - $56.99 $8.03 Million - $10.5 Million
-183,442 Reduced 20.67%
703,931 $38.1 Million
Q1 2023

May 12, 2023
SELL
$43.8 - $56.99 $8.03 Million - $10.5 Million
-183,442 Reduced 20.67%
703,931 $38.1 Million
Q4 2022

Oct 07, 2024
BUY
$44.07 - $54.45 $11.2 Million - $13.8 Million
253,915 Added 40.08%
887,373 $47 Million
Q4 2022

Feb 10, 2023
SELL
$44.07 - $54.45 $49.9 Million - $61.6 Million
-1,131,313 Reduced 56.04%
887,373 $47 Million
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $7.16 Million - $10.1 Million
167,737 Added 9.06%
2,018,686 $93.9 Million
Q2 2022

Aug 12, 2022
SELL
$43.0 - $65.64 $5.61 Million - $8.56 Million
-130,407 Reduced 6.58%
1,850,949 $106 Million
Q1 2022

May 13, 2022
SELL
$38.74 - $62.09 $5.79 Million - $9.28 Million
-149,464 Reduced 7.01%
1,981,356 $121 Million
Q4 2021

Feb 11, 2022
BUY
$35.2 - $53.42 $1.51 Million - $2.29 Million
42,786 Added 2.05%
2,130,820 $112 Million
Q3 2021

Nov 09, 2021
SELL
$28.72 - $42.49 $1.65 Million - $2.45 Million
-57,554 Reduced 2.68%
2,088,034 $77.8 Million
Q2 2021

Aug 11, 2021
BUY
$29.3 - $44.5 $687,026 - $1.04 Million
23,448 Added 1.1%
2,145,588 $87.6 Million
Q1 2021

May 11, 2021
BUY
$30.8 - $39.51 $65.4 Million - $83.8 Million
2,122,140 New
2,122,140 $72 Million

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.09B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email